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Abstract Healthcare services are often provided to a
country as a whole, though in many cases the available
resources can be more effectively targeted to specific
geographically defined populations. In the case of malaria,
risk is highly geographically heterogeneous, and many
interventions, such as insecticide-treated bed nets and
malaria community health workers, can be targeted to
populations in a way that maximises impact for the
resources available. This paper describes a framework for
geographically targeted budget allocation based on the
principles of cost-effectiveness analysis and applied to
priority setting in malaria control and elimination. The
approach can be used with any underlying model able to
estimate intervention costs and effects given relevant local
data. Efficient geographic targeting of core malaria inter-
ventions could significantly increase the impact of the
resources available, accelerating progress towards elimi-
nation. These methods may also be applicable to priority
setting in other disease areas.
Key Points for Decision Makers
Geographic heterogeneity in disease risk and other
factors is important to malaria control and
elimination policy.
Yet geographic heterogeneity does not feature
prominently in the malaria economic evaluation
evidence base.
This paper describes an approach to geographic
allocation of a malaria budget based on cost
effectiveness.
1 Introduction
Effective spending is critical to malaria control and elim-
ination. While global financing for malaria has risen con-
siderably in recent years [1], it is not possible to provide all
malaria interventions to all areas at risk. In addition to
ensuring sustained financial and political commitment,
policy makers must determine how best to marshal the
available resources to maximise impact on malaria burden.
Economic evaluation aims to address this question by
providing information on the health impact of interventions
in proportion to the resources required.
Several reviews have sought to summarise the evidence
base on the cost effectiveness of malaria interventions
[2–4]. This evidence has most clearly informed malaria
policy when an intervention was shown to be highly cost
effective in a wide range of settings, supporting general-
isable policy recommendations. Examples include the use
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of artesunate for the treatment of severe malaria [5] and the
introduction of point-of-care or rapid diagnostic tests [6–8].
However, translating the cost-effectiveness evidence base
to inform detailed malaria control and elimination planning
can be challenging, as described in an accompanying
paper.
1.1 The Importance of Geographic Variation
in Malaria Policy
The national malaria control programme manager is faced
with, among other things, a toolbox of interventions, a
limited budget and a map of malaria risk. With increasingly
abundant geo-data on malaria incidence and the use of
spatial–statistical models to fill in the gaps [9–11], malaria
risk maps are increasingly useful and becoming more
popular as there is growing recognition of the high degree
of heterogeneity in risk within countries, within provinces
or districts, and even within communities [12]. Related to
this, most malaria interventions are highly divisible, down
to the community or patient level, and can be targeted to
specific geographically defined populations. These inter-
ventions include insecticide-treated bed nets (ITNs),
chemoprevention, indoor residual spraying, larviciding,
early detection and treatment through malaria community
health workers (CHW), mass treatment and, perhaps soon,
vaccination.
In addition to disease risk, further factors that vary with
geography are relevant to malaria programming, such as
access to treatment and the higher cost of delivering ser-
vices in remote areas, though the cost of such services may
well be considered worthwhile. In many countries, efforts
are being made to identify the human and ecological
dynamics behind geographic heterogeneity in malaria risk
[13, 14]; trials are underway to identify packages of
interventions that could successfully target malaria hot-
spots [15] and spatial decision-support systems are being
established [16, 17]. Locating malaria risk and deciding
how to respond to this risk is therefore essential to effective
control and elimination.
1.2 Geographic Heterogeneity and Economic
Evaluation
While geographic heterogeneity is clearly important to
malaria policy making, it does not feature prominently in
malaria economic evaluations. The impact of variation in
malaria risk on cost effectiveness can be, and often is,
assessed by univariate or probabilistic sensitivity analysis.
This risks conflating an important distinction between
heterogeneity and uncertainty; it may be useful to the
decision maker to understand both the differences between
geographies and the degree of confidence in this
information. Detailed stratification of cost-effectiveness
results by disease risk would allow readers to match the
characteristics of their context with study findings. How-
ever, geographic variation may include multiple variables
preventing clear stratification.
Economic evaluation can do more to integrate infor-
mation on geographic variability in situations where this is
central to the policy response. There are several recent
examples of studies that model geographic resource allo-
cation for countries or regions in malaria and other disease
areas [18–20]. Though aiming to reconcile costs and con-
sequences, such studies are not always described as eco-
nomic evaluations, often originating in the disciplines of
mathematical modelling or spatial epidemiology. This
paper describes an approach to geographic resource allo-
cation grounded in economic evaluation methodology.
2 Geographic Resource Allocation
Healthcare economic evaluation models provide estimates
of the cost and health impact for interventions of interest.
Given relevant local data on demographics, disease risk
and other factors for a set of geographically defined pop-
ulations (hence ‘geo-units’), such models can provide a
menu or league table of interventions or intervention
combinations in terms of their expected costs and effects.
That is, a modelled estimate of the cost and effect of each
intervention option in each geo-unit. The interpretation of
such a dataset is not trivial, and the decision problem
addressed in this paper is to select intervention options for
each geo-unit such that health gains are maximised given
the resources available.
A wide range of methods are available to model inter-
vention costs and effects, including decision trees, com-
partmental or Markov models and individual-based models
[21–23]. Some considerations in model design may include
intervention interactions, the impact on disease transmission
as well as health, the marginal effects of one intervention in
the presence of another, variations over time and population
behaviour, to name a few. Where multiple interventions are
being considered, the model may need to be able to simulate
their impact in isolation and in varying combinations. It is
important to use an outcome measure that adequately cap-
tures the impact of all interventions of interest; utilitymetrics
including the disability-adjusted life-year (DALY) or qual-
ity-adjusted life-year are appropriate, though some disease-
specific measures such as reduction in prevalence may be
sufficient. Notwithstanding the above, all models are sim-
plifications of reality, and the model should be no more
complex than is necessary to reasonably estimate interven-
tion costs and effects. The literature on modelling economic
and health impacts is extensive.
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2.1 Allocation Method
Geographic resource allocation is a variation of the knap-
sack problem1 and is analogous to priority setting between
healthcare domains in standard healthcare priority setting
using cost-effectiveness or cost-utility analysis [24]. The













The sum of intervention effects (e) is maximised subject
to a budget constraint (b) on the sum of intervention costs
(c), where the set of all interventions (i) in all geo-units
(g) are included or excluded using a decision variable (d).
The decision variable determines inclusion or exclusion of
intervention options and normally d [ {0, 1}. Obtaining a
solution to the optimisation problem is more
tractable given an assumption of divisibility (see Sect. 2.3).
The allocation algorithm described here is an adaptation
of priority setting using cost-effectiveness analysis rather
than an iterative trial-and-improvement optimisation solver
and is illustrated with a simplified example of a decision
problem in three geographic units: A, B and C. Two
interventions, ITNs and malaria CHWs, are available, as
well as the combination of both interventions and the
option to provide neither. Figure 1, panel 1, presents this
example graphically, with information on the costs, effects
and allocation results in Table 1. The corresponding cost-
effectiveness plane and the allocation result is presented in
Fig. 1, panel 2, and the steps of the allocation algorithm are
summarised in Box 1.
Starting with the costs and effect estimates for all
intervention options in all geo-units, all dominated inter-
ventions (those that are more costly and less effective than
an alternative intervention within the same geo-unit) are
excluded. Incremental cost-effectiveness ratios (ICERs) are
calculated for all interventions using the null or ‘no addi-
tional intervention’ scenario as the comparator. Priority
setting is then broken down into a series of decisions. The
first decision selects the intervention option with the lowest
ICER from all non-excluded options in all geo-units. This
selection is the choice that produces the maximum
expected health gains for the investment (though it may be
replaced by a subsequent selection in the same geo-unit).
The cost of the intervention is subtracted from the budget,
and the ICERs for the remaining interventions in the same
geo-unit are recalculated using the selected intervention as
the comparator (see Sect. 2.2). Any recalculated ICERs that
are negative are subject to extended domination and
excluded. These recalculated ICERs are those that form the
cost-effectiveness frontier for the geo-unit. These steps are
repeated, selecting the most cost-effective intervention
option, recalculating the ICER and adjusting the budget. If
the selection is in a geo-unit for which an intervention is
already allocated, the new selection displaces the previous
one and the cost of the displaced intervention is returned to
the running budget. The process ends when the remaining
budget is less than the cost of the next most cost-effective
option.
Given the challenges specifying and interpreting cost-
effectiveness thresholds (CETs) for malaria control and
elimination [25], the approach uses a budget as the resource
constraint, which, because of the role of international aid, is
often known and ring-fenced. Alternatively, if we instead
wish to apply a CET as the resource constraint, each geo-
unit can be treated as an isolated decision problem. As
before, interventions subject to domination by others within
the same geo-unit are excluded. Then, following standard
economic evaluation methods, the cost-effectiveness fron-
tier is identified and ICERs calculated sequentially along
this frontier. The intervention option with the highest ICER
below the CET is the expected optimal choice in each geo-
unit.
Box 1 Geographic resource allocation steps
The starting point of this method is a set of cost and effect
estimates for all intervention options in all geographic units of
interest. The aim is to select interventions and intervention
bundles by geo-unit in such a way that impact is maximised for a
given budget
1. Remove all interventions where there exists an alternative
within the same geo-unit that is both more effective and less
costly (absolute domination)
2. Calculate ICERs for all intervention combinations in all geo-
units using a common ‘no additional intervention’ comparator
3. Considering all remaining intervention options in all geo-units,
select the option with the lowest ICER to allocate funding.
Reduce the budget by the cost of this selection
4. If the selection displaces another intervention option in its geo-
unit, then remove the displaced option from the league table and
add its cost to the running budget
5. Recalculate the ICER for any remaining interventions in the
selection geo-unit, using the newly selected intervention option
as the comparator
6. Remove any intervention options where the ICER is negative
(extended domination, the intervention is not absolutely
dominated yet does not fall on the cost-effectiveness frontier and
thus is not selected at any point)
7. Repeat steps 3-6 until the running budget is less than the cost of
the next selection
ICER incremental cost-effectiveness ratio
1 A standard combinatorial optimisation of placing objects of
different weights into a knapsack.
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2.2 Incremental Cost-Effectiveness Ratio
Calculation: Which Comparator?
When evaluating intervention options across multiple geo-
units, identification of the appropriate comparator is
essential to calculation of the correct ICER. Where a new
intervention selection replaces a previous one, the differ-
ence in costs and effects between these alternatives should
be used to decide whether the additional investment justi-
fies the additional benefit. In this respect, there is a
difference in resource allocation within and between pop-
ulation groups in that within-group selection is alternative
whereas between-group selection is additive.
Figure 2 illustrates this using the second decision step in
the example; after selection of ITN in population A, the
next choice can be to add ITN in population B or C or to
replace ITN in population A with the ‘both’ option in
population A (CHW only is dominated in the example). If
one intervention will replace another, the appropriate

































Fig. 1 Illustrative geographic allocation with cost-effectiveness
plane (matching Table 1). Panel 1: A, B and C are illustrative geo-
units corresponding to the example described in Sect. 2.1 and Table 1.
The highlighted segments denote the intervention options selected to
receive funding in the example. Abs. absolutely, Ex. extended, CHW
community health worker, ITN insecticide-treated bed net















A ITN 3.73 304 82 82 Displaced 1
CHW 3.4 380 112 – Abs.
dominated
Both 5.01 498 99 152 Funded 3
B ITN 3.41 501 146 146 Displaced 2
CHW 3.62 733 202 – Ex. dominated
Both 4.29 804 187 344 Funded 5
C ITN 3.01 533 177 177 Funded 4
CHW 3.27 767 235 900 Unfunded
Both 3.38 933 276 1509 Unfunded
Abs. absolutely, CHW community health worker, DALY disability-adjusted life-year, Ex. extended, ICER incremental cost-effectiveness ratio,
ITN insecticide-treated bed net
a A by-product of the allocation process is the cost-effectiveness threshold or willingness to pay implied by the relevant budget. The threshold
would fall between the least cost-effective intervention that is funded and the most cost-effective intervention that is not. In the example in
Table 1, this is between $US344 and $US900 per DALY averted
b Given a budget constraint of $US2000
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difference between the costs and health gains between
these interventions.
Calculation of the correct ICERs emerges in the process
of the algorithm described in Sect. 2.1. At the point of
selecting an intervention for inclusion, the ICERs for all
remaining interventions within the same geo-unit are
recalculated with the selected intervention as comparator,
reflecting that, within a geo-unit, a new selection will
replace the previous selection.
2.3 Geo-Units
To address a practical budget allocation problem, the geo-
units are likely to be pre-established administrative con-
stituencies such as districts, townships or perhaps villages.
The choice of administrative level should reflect how the
interventions of interest may realistically be implemented.
For example, for reasons of pragmatism and economies of
scale, it may be more appropriate to allocate mass distri-
bution of goods such as ITNs by district or township rather
than by village. It is also essential that information such as
population and disease risk must be available for the cho-
sen administrative level. It may also be beneficial to
include variable costs for different geo-units and for pro-
gramme scale [26, 27].
Lastly, sequential selection based on ICERs does not
necessarily provide a perfectly optimal solution for a dis-
crete allocation problem in that there is a degree of error
associated with the residual underspend [28]. In cost-ef-
fectiveness analysis, decision divisibility is assumed,
allowing partial implementation of interventions. That is,
the decision variable (d) in the knapsack objective function
(Sect. 2) may take fractional values. While the assumption
of divisibility in cost effectiveness has been debated
[29–31], it is reasonable in the context of geographic tar-
geting, where divisibility of intervention decisions by
geographic areas is already assumed. Moreover, in the
geographic allocation methods described here, the divisi-
bility assumption is only necessary at the margin. That is,
at the end of the allocation algorithm, it is assumed the
most cost-effective unfunded intervention geo-unit option
could be partially implemented using the remaining funds.
It may not be necessary to formally include the partial unit
allocation, as the interpretation of results would not reflect
such precision (see Sect. 3.1), as in cost-effectiveness
analysis, an underlying assumption of divisibility may be
sufficient.
2.4 Uncertainty
Assessing and communicating the robustness of results
given uncertainty in the model inputs is essential for rig-
orous economic evaluation. Probabilistic uncertainty can
be incorporated into the allocation analysis by assigning
sampling distributions to input variables and making
repeated simulations of the allocation result (Monte Carlo
simulation). A clear distinction can be made between this
variation due to uncertainty and variation due to hetero-
geneity, and this is incorporated into the resource alloca-
tion analysis described above. The result of a probabilistic
uncertainty analysis would be a probability score for each
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Fig. 2 Graphical representation of within and between geo-unit
selection having initially selected ITN in geo-unit A. Panel 1: A,
B and C are illustrative geo-units corresponding to the example within
vs. between geo-unit selection described in Sect. 2.2. The darker
highlighted ITN segment in geo-unit A denotes the intervention
selected in the first step; the lighter highlighted segments denote the
three options available for selection in the second step. Panel 2
represents the corresponding cost-effectiveness plane. CHW commu-
nity health worker, ITN insecticide-treated bed net
Geographic Resource Allocation in Malaria Policy Making 303
given the defined parameter uncertainty. In such a proba-
bilistic (or Bayesian) framework, additional decision cri-
teria can be incorporated to reflect decision maker
preferences such as aversion to overspend or undersupply
[32, 33]. Univariate or multivariate sensitivity analysis or
scenario analysis can be used to assess parameter impor-
tance and scenarios of interest. Finally, structural uncer-
tainty can be examined by repeating the allocation analysis
with different underlying malaria models.
2.5 Case Study: Universal Insecticide-Treated Bed
Net Coverage vs. Targeted Resource Allocation
in Myanmar
A geographic resource allocation approach is employed by
Drake et al. [19] to examine the cost effectiveness of ITN
and malaria CHW in the Myanmar Artemisinin Resistance
Containment (MARC) region [19]. Here, we use scenarios
from the same context to illustrate the comparative
advantage of targeted resource allocation over universal
coverage (Fig. 3).
Based on the parameters detailed in Drake et al. [19],
universal ITN coverage in the MARC region has an annual
equivalent cost of $US6.08 million. The expected total
impact of this compared with a hypothetical ‘do nothing’
scenario is 2156 DALYs averted. In comparison, the same
budget allocated to ITNs, malaria CHWs or both by
township on the basis of cost effectiveness yields a total
impact of 2458 DALYs averted, a 14% increase in impact
compared with universal coverage in the first year without
including reduction in transmission. It is worth noting that
this is within a region already identified as high priority for
malaria control efforts; application to the country as a
whole or wider regions could yield greater efficiencies.
Effectively targeted malaria interventions have the poten-
tial for greater impact than universal coverage of a single
‘most cost-effective’ intervention. This is already a com-
mon view in many policy circles. Economic analysis can
do more to support geographic targeting in malaria control
and elimination.
3 Discussion
This paper describes an approach for the geographic allo-
cation of a given budget using locally specific estimates of
the costs and effects of multiple interventions or inter-
vention bundles. This framework is described in the con-
text of malaria policy making but could be equally relevant
in other disease contexts, such as schistosomiasis and soil-
transmitted helminths [34] or HIV/AIDS [18].
3.1 Interpretation
A strength of this approach is that results are clear and
directly applicable to the planning process, offering
recommendations not only as to which interventions to
invest in but where to target them to maximise health
gains. Moreover, the recommendations are constrained
by a relevant budget rather than a CET that, if too
high, may recommend unaffordable policies or, if
reflecting societal affordability constraints, may
underestimate available resources because of interna-
tional aid. In the context of malaria, budget-based
geographic targeting can better reflect a real and timely
decision problem than generalised threshold-based
economic evaluations.
Nevertheless, a model is a simplification of a complex
process and should be interpreted as such. All model
inputs, the structure of the underlying model and the
resource allocation framework are necessarily limited.
While the model results may offer one recommendation,
decision makers often have rich knowledge of the local
context and should interpret model results as a potentially
useful synthesis of relevant information that is nonetheless
a simplification.
Fig. 3 Geographic allocation of budget for universal insecticide bed
net coverage compared with targeting of both bed nets and
community health workers. a Universal bed net coverage (within
the MARC region) compared with b geographic targeting of both bed
nets and community health workers. CHW community health worker,
DALY disability-adjusted life-year, ITN insecticide-treated bed net,
MARC Myanmar Artemisinin Resistance Containment
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3.2 Alternative Methods
In addition to the methods outlined in this paper, there are
alternative approaches to geographic resource allocation.
Walker et al. [20] applied a cost-minimisation framework and
simulated a large number of different allocation options,
choosing the least costly configuration that achieved a par-
ticular endpoint such as disease elimination. The approach
differs from budget allocation in that it does not specify a
resource constraint. A possible advantage of this or similar
simulation approaches is that optimal solutions can be found
for allocation problems without making the assumption of
divisibility. A drawback of a simulation approach is the
substantial computation time required, notwithstanding tech-
niques to improve efficiency, such as simulated annealing.
Computation time for the approach described in this paper is
negligible and therefore dependent only on the underlying
cost-effectiveness model. For simple models, probabilistic
sensitivity analysis and interactive user interfaces can be
possible, both of which are potentially valuable extensions.
3.3 Limitations
There are several limitations to the resource allocation
framework described in this paper.
First, all limitations of the underlyingmodel used to estimate
intervention costs and effects apply equally to the allocation
result. Care needs to be taken when comparing allocation
results from different models because characteristics or arte-
facts of the underlyingmodel could drive important differences
in results. Second, the method objective is a simple maximi-
sation of health utility. It may be beneficial in some contexts to
extend the approach to include non-health benefits such as
financial protection [35] or to incorporate equity preferences
[36]. Third, the friction cost of administering targeted, as
opposed to universal, healthcare programmes is not included,
and there may be differences in economies of scale. Incorpo-
ration of scale into a variable cost function would be a valuable
addition. Lastly, the allocation results can only be as good at the
input data. Reliable locally specific information on disease risk
and other variables, such as treatment-seeking behavior or
intervention cost, are essential and not always readily available.
In particular, the potential bias of under-reporting disease bur-
den in areaswith poor health surveillance is problematic for any
geographic targeting based on such data, whether in a formal
allocation framework or otherwise.
4 Conclusion
Geographic targeting is an increasingly common feature of
malaria control and elimination strategies but does not
feature prominently in malaria economic evaluations. This
paper describes a framework for geographic budget allo-
cation grounded in economic evaluation methods. Efficient
targeting of core malaria interventions has the potential to
increase the impact of the resources available, accelerating
progress towards disease elimination. These methods will
also be applicable to priority setting in other disease areas.
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